-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
H.
Infection medsci.
The study was conducted in 55 clinical research bases in the United States and included 455 untreated adult patients with Helicobacter pylori infection who were treated with RHB-105 (amoxicillin, 3 g; omeprazole, 120 mg; rifab).
The results showed that in the intention-to-treat population, the eradication rate of RHB-105 was higher than that of the active contrast agent (228 cases vs.
In summary, these findings indicate that RHB-105 is expected to be an alternative to first-line empirical Helicobacter pylori treatment.
Original source:
David Y Graham, Yamil Canaan, et al.
Leave a message here